Aslan Pharmaceuticals Limited  (ASLN)

Aslan Pharmaceuticals Limited announced operating deficit of $-47.882487 millions, in the fourth quarter of 2022

company delivered fourth quarter of 2022 operating deficit of $-47.882487 millions

Published Mar 26 2023
Goran Soko / CSIMarket.com Contributer

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons While the earnings season of the October to December 31 2022 continues, the most businesses have announced the results. Some of them, are various entities in the Biotechnology & Pharmaceuticals industry. And today, ASLN reported operating deficit of $-47.882487 millions, for the most recent fiscal period.

The operating deficit has depleted from $-33.846452 millions, from the fourth quarter of 2021. But more importantly, the investors are speculating, when the ASLNs' may start to report the revenue.

It is not really a surprise, that the rising firm recorded a net loss of $-51.382 millions, that has swelled from $-31.591 millions, in the same three months a preceding year.

the Biotechnology & Pharmaceuticals company announced shortfall of $-51.38 millions and Revenues of $0.00 millions in the financial period 2022.

Net shortfall per share has widen to $-0.15 from $-0.10 in preceding financial year, while by 0 % from $0.00 millions a year before.

Aslan Pharmaceuticals Limited is expected to report next financial results on March 23, 2024.

Aslan Pharmaceuticals Limited's ROE

Aslan Pharmaceuticals Limited's Income per Employee

Other ASLN's Earnings Reports

Other ASLN's Earnings Reports


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071